209
Views
25
CrossRef citations to date
0
Altmetric
Review Article

Amelioration of cisplatin-induced nephrotoxicity in mice by oral administration of diphenylmethyl selenocyanate

, , &
Pages 177-187 | Received 25 Mar 2010, Published online: 13 Oct 2010

References

  • Rosenberg B. Fundamental studies with cisplatin. Cancer 1985;55:2303–23l6.
  • Coste F, Malinge JM, Serre L, Shepard W, Roth M, Leng M, Zelwer C. Crystal structure of a double-stranded DNA containing a cisplatin intrastrand cross-link at 1.63 Å resolution-hydration at the platinated site. Nucleic Acids Res 1999;27: 1837–1846.
  • Kartalou M, Essigmann JM. Recognition of cisplatin adducts by cellular proteins. Mutat Res 2001;478:1–21.
  • Safirstein RL. Renal diseases induced by anti-neoplasticagents. Schrier RW, Diseases of the kidney and urinary tract. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. 1175–1188.
  • Masuda H, Tanaka T, Takahama UT. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994;203:1175–1180.
  • Baliga R, Zhang Z, Baliga M, Ueda N, Shah S. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998;53:394–401.
  • Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 1998;131:518–26.
  • Sadzuka Y, Shoji T, Takino Y. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol 1992;43:1873–1875.
  • Safirstein R, Miller P, Guttenplan JB. Uptake and metabolism of cisplatin by rat kidney. Kidney Int 1984;25:753–758.
  • Conklin KA. Dietary antioxidants during cancer chemotherapy impact on chemotherapeutic effectiveness and development on side effects. Nutr Cancer 2000;37:1–18.
  • Ozardali I, Bitiren M, Karakilçik AZ, Zerin M, Aksoy N, Musa D. Effects of selenium on histopathological and enzymatic changes in experimental liver injury of rats. Exp Toxicol Pathol 2004;56:59–64.
  • Yan L, Yee JA, Li D, McGuire M, Graef GL. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice. Anticancer Res 1999;19:1337–1342.
  • Arenholt-Bendsleve D, Abdulla M, Jepsrn A, Pedeson E. Effect of organic and inorganic selenium on human keratinocytes. Trace Elem Med 1988;5:29–34.
  • Khalil AM. Genotoxicity of two pharmacologically important selenium compounds (selenocystine and selenopuridine) in cultured human blood lymphocytes. Toxicol Environ Chem 1994;41:147–154.
  • Nogueira CW, Zeni G, Rocha JB. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 2004;104:6255–6285.
  • Meotti FC, Stangherlin EC, Zeni G, Nogueira CW, Rocha JB. Protective role of aryl and alkyl diselenides on lipid peroxidation. Environ Res 2004;94:276–282.
  • Das RK, Das S, Bhattacharya S. Protective effect of diphenylmethyl selenocyanate against carbon tetrachloride induced hepatotoxicity in vivo. J Environ Path Toxicol Oncol 2004;23: 287–296.
  • Ghosh S, Das RK, Sengupta A, Bhattacharya S. Induction of apoptosis and inhibition of cell proliferation by diphenylmethyl selenocyanate during azoxymethane induced rat colon carcinogenesis. Int J Cancer Prev 2005;2:63–70.
  • Chakraborty P, Sk HU, Murmu N, Das JK, Pal S, Bhattacharya S. Modulation of cyclophosphamide-induced cellular toxicity by diphenylmethyl selenocyanate in vivo, an enzymatic study. J Cancer Molecules 2009;4:183–189.
  • Chakraborty P, Sk HU, Bhattacharya S. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate. Cancer Chemother Pharmacol 2009;64:971–980.
  • Pederson CTH. Preparation of some 4-substituted selenosemicarbazides. Acta Chemica Scandinavica 1963;17:1459–1461.
  • Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thioberbituric acid reaction. Annal Biochem 1979;95:351–358.
  • Sedlack J, Lindsay RN. Estimation of total protein bound and non-protein sulphydryl groups in tissue with ellman reagent. Annal Biochem 1968;25:192–205.
  • Habig WH, Pabst MJ, Jacoby WB. Glutathione-S-transferase, the first enzymatic step in marcapturic acid formation. J Biol Chem 1974;249:7130–7139.
  • Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158–169.
  • Luck HA. Spectrophotometric method for estimation of catalase Bergmeyer HV, Methods of enzymatic analysis. New York: Academic Press; 1963. 886–888.
  • Marklund S, Marklund G. Involvement of the superoxide anion radical in autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47: 469–474.
  • McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemoprotein). J Biol Chem 1969;244:6049–6055.
  • Green LC, Luzuriaga RKD, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 1981;78:7764–7768.
  • Carl Allinson MJ. A specic enzymatic method for the determination of creatine and creatinine in blood. J Biol Chem 1944;16:169–174.
  • Mather A, Roland D. The automated thiosemicarbazide-diacetyl monoxime method for plasma urea. Clin Chem 1969; 15:394–396.
  • Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folinphenol reagent. J Biol Chem 1951; 193:265–276.
  • Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the post initiation stage of colon carcinogenesis. Cancer Res 1997;57:3465–3470.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.
  • Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 1999;31:971–997.
  • Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 2003;142:178–186.
  • Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem 1998; 178:127–133.
  • Rana SV, Allen T, Singh R. Inevitable glutathione, then and now. Ind J Exp Biol 2002;40:706–716.
  • Mistry P, Merazga Y, Spargo DJ, Riley PA, McBrien DC. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother Pharmacol 1991;28:277–282.
  • Hayes JD, Pulford DJ. The glutathione-S-transferase supergene family: regulation of GST and the contribution of isoenzyme to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445–600.
  • Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998;53:394–401.
  • Michel T, Feron O. Nitric oxide synthase: which, where, how, and why? J Clin Invest 1997;100:2146–2152.
  • Srivastava RC, Farookh A, Ahmad N, Misra M, Hasan SK, Husain MM. Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals 1996;9: 139–142.
  • Kuhad A, Tirkey N, Pilkhwal S, Chopra K. 6-Gingerol prevents cisplatin-induced acute renal failure in rats. Biofactors 2006;26:189–200.
  • Chirino YI, Hernandez-Pando R, Pedraza-Chaveri J. Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol 2004;30:4–20.
  • Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthase (cyclooxygenases)-1 and 2. J Biol Chem 1996;271:33157–33160.
  • Ledinghen V, Liu H, Zhang F, Lo CR, Subbarmaiah K, Dannenberg AJ, Czaja MJ. Induction of cyclooxygenase-2 by tumour promoters in transformed P4502E1-expressing hepatocytes. Carcinogenesis 2002;23:73–79.
  • Masfferer JL, Seibert K, Zwefel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992;89:3917–3921.
  • Sirois J, Richards JS. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin ingranulosa cells of rat preovulatory follicles. J Biol Chem 1992;267: 6382–6388.
  • Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the post initiation stage of colon carcinogenesis. Cancer Res 1997;57:3465–3470.
  • Tao L, Kramer PM, Wang W, Yang S, Lubet RA, Steele VE, Pereira MA. Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short term treatment with chemopreventive agents. Carcinogenesis 2002;23: 1447–1454.
  • Lieberthal W, Triaca V, Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 1996;270:700–708.
  • Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatin associated nephrotoxicity and pathological events. Contrib Nephrol 2005;148:107–121.
  • Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004; 195:221–230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.